Saturday, June 7, 2025

No Result

View All Result

Media

Support Us

No Result

View All Result

Health

Life on hold – How Canada’s drug approval delays endanger patients: Nigel S.B. Rawson and John Adams

March 13, 2025

John Adams

Inside Policy

Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy

July 19, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada – part 1, regulatory approval: Nigel Rawson and John Adams for Inside Policy

July 12, 2023

The U.S. outsources control of drug prices to Canada: weird! Richard Owens in the Financial Post

Columns

The drug prices review board was once a solution. It’s now a problem: Nigel Rawson and John Adams in the Financial Post

March 1, 2023

Columns

For drug access, Canadians with rare disorders are 40 years behind Americans: Nigel Rawson and John Adams in the Financial Post

January 24, 2023

Can we afford National Pharmacare and do people want it? Jeffrey Simpson for Inside Policy

Columns

PMPRB continues plan to drive down drug prices as patients suffer: Nigel Rawson and John Adams for Inside Policy

November 23, 2022

Build health care back better: Philip Cross in the Financial Post

Columns

Suffer from a rare disorder in Canada? Good luck: Nigel Rawson and John Adams in the Financial Post

November 2, 2022

The Patented Medicine Prices Review Board is selling Canadians a lemon: Nigel Rawson for Inside Policy

Health

Ottawa should reset its relationship with drug developers to improve patient health: Rawson and Adams for Inside Policy

May 2, 2022

Health

‘Big Tobacco’ COVID-19 vaccine: What were the Liberals thinking? Nigel Rawson and John Adams in the Financial Post

April 22, 2022

Domestic Policy

The Macdonald-Laurier Institute Welcomes Newest Senior Fellows, Nigel Rawson and John Adams

April 11, 2022

Page 3 of 3 Prev 1 2 3

Newsletter Signup

Email Address *

First Name *

Last Name *

*Required Fields

Follow us on

Macdonald-Laurier Institute

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

No Result

View All Result

Life on hold – How Canada’s drug approval delays endanger patients: Nigel S.B. Rawson and John Adams

John Adams

Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada – part 1, regulatory approval: Nigel Rawson and John Adams for Inside Policy

The drug prices review board was once a solution. It’s now a problem: Nigel Rawson and John Adams in the Financial Post

For drug access, Canadians with rare disorders are 40 years behind Americans: Nigel Rawson and John Adams in the Financial Post

PMPRB continues plan to drive down drug prices as patients suffer: Nigel Rawson and John Adams for Inside Policy

Suffer from a rare disorder in Canada? Good luck: Nigel Rawson and John Adams in the Financial Post

Ottawa should reset its relationship with drug developers to improve patient health: Rawson and Adams for Inside Policy

‘Big Tobacco’ COVID-19 vaccine: What were the Liberals thinking? Nigel Rawson and John Adams in the Financial Post

The Macdonald-Laurier Institute Welcomes Newest Senior Fellows, Nigel Rawson and John Adams

Top News

Canadian Medical Association wants to force Alberta to ignore science on gender care: Mia Hughes in the National Post

Trump’s populism has infantilized the presidency: Aurel Braun in the National Interest

Free markets and liberty are not ends unto themselves: Oren Cass and Peter Copeland for Inside Policy Talks

Multimedia

Does Ontario actually need tougher judges? Peter Copeland on The Agenda

How Did Trump Impact the Canadian Election? Brian Lee Crowley on American Thought Leaders

How provincial trade barriers rip off Canadians: Peter Copeland & Ryan Manucha for Inside Policy Talks

Medical organizations and media let Canadians believe gender medicine is safe and universally accepted. It’s not: 14 physicians author statement for Inside Policy

(Im)balance of power – How federal overreach fuels Western Alienation: Sonya Savage and Heather Exner-Pirot

Hybrid threats, broken borders, and organized chaos—transnational organized crime in Canada: Inside Policy Q&A with Cal Chrustie

Fighting mortgage fraud in Canada: Cameron Field

Unleashing AI: Canada’s blueprint for productivity, innovation, and workforce integration

Newsletter Signup

Follow us on

Macdonald-Laurier Institute

Support Us